Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

CI · The Cigna Group

$305.78 -0.38% Oct 26 close
Detected setup Golden Cross · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about CI

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$CI

The Cigna Group

The Cigna Group is a large-cap Managed Health Care company in the Health Services sector with a market cap of $81B.

Health Services Managed Health Care stock Stage 2 · Advancing Base 3+
$305.78 latest close
Market Structure
Trend structure: downtrend
Latest event: bos (bearish)
Support 270.42–278.00 · 14 touches · strong
Support 257.85–259.00 · 4 touches · moderate
Support 285.67–286.81 · 4 touches · moderate
Support 278.86–279.67 · 4 touches · moderate
Support 267.52–268.80 · 3 touches · moderate
Verdict · setup score 55/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$280$300$320AugSepOct$306

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.4 50-day MA > 150-day MA AND 200-day MA — MA50 $282.22, MA150 $282.44, MA200 $281.19
  • Minervini 1.8 RS rank ≥ 70 (prefer ≥ 85) — RS rank 53
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -3.6% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 53
  • Weinstein Volume expansion above average — Volume ratio 1.17x
  • Weinstein Relative strength ≥ 60 — RS 53
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails 50-day MA > 150-day MA AND 200-day MA.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.
54 Neutral
Legend Score · rates the stock Neutral (54/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 53
  • Trend Template (25%) 62
  • Institutional Footprint (20%) 69
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 53: middle of the pack — no leadership yet. Trend template 5/8: mixed — some uptrend elements, some missing. Institutional score 69: mild accumulation. EPS -0% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Wednesday, October 28, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

CI-0.38%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. CI was -0.38 points vs XLV. -1.09 points vs SPY.
CatalystPending Stock reactionNegative Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-0.38% From the open-0.43% Range position20% GapNo gap
QQQ confirmationDiverging (+1.11%) SMH confirmationDiverging (+2.74%)
Short-term conviction -2 points.
  • QQQ, SMH moved against the stock — no index confirmation.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $305.78 -0.4% Oct 26 close
52W High $316.27 3.3% below high
Wks Since High 0w
Base Depth 3.7%
RS Rank 15 percentile of scan
SMA 50 $282.22
Avg Vol 1,525,708
Rel Vol (Oct 26) 1.17× 1.36× on up days
More stats
52W Low $239.51
Tight Wks 0
Base B3
SMA 200 $281.19
RS Line vs High -11.5%
RS Line Slope +10.9% ▲
Group Rank #23/66
ADR% 2.7%
ATR(14) $7.75 (2.5%)
Vol Pace (live) N/A
A/D Days 20A / 17D
A/D Rating A
VDU Bars 0/10 d
Power Trend 9d
Earnings tomorrow
Position in 52-week range 86thpercentile of the 52-week range
$239.51low
$316.27high

CI Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for CI.

Create Free Account

Technical Analysis Report Card

$CI · $305.78 · as of 2026-10-26 · multi-factor read
99
/ 100
Technicals 99/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$282.22 ↑
100-day$284.13 ↑
200-day$281.19 ↑
Golden Cross (fresh)

RSI (14)

Reading63.5 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+2.524

Bullish — MACD above its signal line and above zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width79% · 20.9%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.36 · Neutral
Rel volume1.17×
Pocket pivots · 10d3
5d vs 50d vol104%
Heavy vol up / down0 / 1

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

  • Pocket pivot 2 sessions ago — up-day volume beat every down day of the prior 10 sessions.
  • 1 heavy-volume down day vs 0 up in the last 20 sessions — supply is showing.

Support & Resistance

R · $316.2752-week high
Price · $305.78now
S · $278.86swing level
S · $273.71swing level
S · $263.94swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$303.66
38.2%$295.86
50.0%$289.56
61.8%$283.26
78.6%$274.28

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CI — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about CI
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (55/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 6 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid D Trend-template read: fails 50-day MA > 150-day MA AND 200-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $305.78, MA150 $282.44, MA200 $281.19
1.2 150-day MA > 200-day MAMA150 $282.44 vs MA200 $281.19
Failing evidence
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $282.22, MA150 $282.44, MA200 $281.19
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 53
7/13 checks
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
N: Near 52-week high or RS line new high3.3% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.54%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-3.6% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 53
2/8 checks
Weinstein Watch C Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

mediumStage 2 uptrend in progress — hold as long as price stays above the 30-week moving average.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $305.78 vs MA200 $281.19
Failing evidence
Volume expansion above averageVolume ratio 1.17x
Relative strength ≥ 60RS 53
4/7 checks
dennis Watch C Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $262.85
Volatility-unit sizing (1N ≈ 1% of equity)1N = $7.47 (2.44% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/8 checks
zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $351.65-$366.94; trail the rest
Failing evidence
Named Zanger pattern onlyGolden Cross is not one of Zanger's six
Breakout volume 1.5-2.0x averageNot confirmed
4/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying; Price strength (RS ≥ 70) — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 13.8x — no PEG or forward P/E stored
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (1995 adv / 1699 dec) — participation expanding
Failing evidence
EPS growth above the market (≥15% QoQ)-3.6% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
3/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$305.78
Distance from 52-week high3.3% below high
Failing evidence
Relative strengthRS 53
Volume vs average1.17x
3/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$305.78
Distance from 52-week high3.3% below high
Failing evidence
Relative strengthRS 53
Volume vs average1.17x
3/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$305.78
Distance from 52-week high3.3% below high
Failing evidence
Relative strengthRS 53
Volume vs average1.17x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
89RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -2 A
A: 13 D: 15 Net: -265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -4%
✗ Revenue growth ≥20% YoY +11%
✗ Gross margin ≥30% 9%
✗ ROE ≥17% 15%
✗ RS rating ≥80 (leadership) 53
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -3.3%

Method Playbook

Trade it like Weinstein EXACT LEVELS · PRO
Weinstein C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Golden Cross ⚠ 3rd-stage base ⚠ Not actionable yet
55 setup score
RS Score 53
Trend template 5/8
CANSLIM 66.5* (B)
fast len: 50 slow len: 200 detector version: golden_cross/2026-09-27 cross bar ago: 2 cross price: 281.18 fast now: 282.22 slow now: 281.19 separation pct: 0.37 volume ratio: 1.058 depth pct: 1.98 geometry: {'cross_point': {'bar': 370, 'bars_ago': 2, 'price': 281.18, 'date': '2026-10-22'}, 'ring': {'bar': 370, 'bars_ago': 2, 'price': 281.18, 'date': '2026-10-22', 'color': 'gold', 'label': 'Golden Cross'}, 'fast_ma_line': {'label': '50-day SMA', 'start': {'bar': 313, 'bars_ago': 59, 'price': 286.4644, 'date': '2026-08-03'}, 'end': {'bar': 372, 'bars_ago': 0, 'price': 282.2234, 'date': '2026-10-26'}}, 'slow_ma_line': {'label': '200-day SMA', 'start': {'bar': 313, 'bars_ago': 59, 'price': 279.8315, 'date': '2026-08-03'}, 'end': {'bar': 372, 'bars_ago': 0, 'price': 281.1888, 'date': '2026-10-26'}}} confidence kind: heuristic_match findings: ['50-day SMA crossed above the 200-day SMA at ~$281.18 (2026-10-22, 2 bars ago)', 'Now: 50-day SMA $282.22 vs 200-day SMA $281.19; price $305.78 holding above the slow line', 'The fast average fell 2.0% from its pre-cross peak — this cross resolves that consolidation'] validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 5/8 confirmed
Why This Setup? D+W Confluence
Golden Cross · schematic

Golden Cross: the 50-day SMA just crossed above the 200-day SMA (~$281.18, 2 bars ago) — the classic long-term trend-turn signal. Price is holding above the slow line. Research/educational only, not a buy/sell recommendation. | Moderate trend (5/8) | High-confidence pattern (76%) | Power Trend | Stage 2 | Readiness 52/100 (early) | CANSLIM 66.5 (B) | ⚠ 3rd-stage base; Not actionable yet

Wyckoff SOS ⚠ 3rd-stage base ⚠ Not actionable yet
55 setup score
RS Score 53
Trend template 5/8
CANSLIM 68.1* (B)
range low: 274.448 range high: 296.879 range pct: 0.082 sos thrust: 0.007 sos vol ratio: 1.22 sos bars ago: 7 near lps: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup? D+W Confluence
Wyckoff SOS · schematic

SOS: breakout above range_high=296.88, thrust=0.7%, vol=1.2x avg, lps=near, 7 bars ago | Moderate trend (5/8) | Moderate pattern (68%) | Power Trend | Stage 2 | Readiness 60/100 (early) | CANSLIM 68.1 (B) | ⚠ 3rd-stage base; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

3/7 universals met
  • A relative-strength leader — not met RS rank 15 — laggard
  • Clear of earnings — not met in 1 days — event risk
  • Not chasing (in range) — not met Not met — levels are a Pro detail
  • Volume confirms — partly met 1.2× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 5/8
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $305.78 vs SMA150 $282.44 / SMA200 $281.19
SMA 150 above SMA 200 SMA150 $282.44 vs SMA200 $281.19
SMA 200 trending up Slope +1.23 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $282.22
Price above SMA 50 $305.78 vs SMA50 $282.22
30%+ above 52-week low +27.7% from $239.51
Within 25% of 52-week high -3.3% from $316.27
RS score above 70 RS 53

Fundamentals

52W Range
86%
Mkt Cap SEC
80.8B
EPS QoQ
-4%
Rev YoY
+11%
ROE
15%
Gross Margin
9%
D/E
0.75
EPS TTM
$22.18
P/E TTM
13.8x
Float
264M
Insider
No Buy

Company

Company profile
The Cigna Group
CI · NYSE · Health Services · Managed Health Care
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 66.5* CANSLIM * disqualified on C, M
C · Curr. EPS
50
A · Annual EPS
72
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
53
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
5/8
W. RS
69
W. Support
$262.85
W. Resist
$316.27
W. Patterns
Base Breakout Basing Symmetrical Triangle Golden Cross
Weekly Structure

Scan History

20× streak
Oct 23: 55 (Golden Cross)Oct 23: 72 (Wyckoff SOS)Oct 26: 55 (Golden Cross)Oct 27: 55 (Golden Cross)55
Oct 27
Golden Cross
55
Oct 26
Golden Cross
55 0.0%
Oct 23
Wyckoff SOS
72 -0.4%
Oct 23
Golden Cross ✓ Gate
55 -0.4%

Latest News

Headlines for CI
Loading headlines…

Get the full picture on CI

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial